Telemedicine for Pediatric Sickle Cell Patients in Medically Underserved Areas

About the study

The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consumer) for use with children with SCD using caregiver input from our preliminary K12 work. Aim 2: Demonstrate the feasibility of the telemedicine models developed in Aim 1 as the models undergo successive stakeholder refinement during use in actual clinical care. Aim 3: Evaluate the effectiveness of the refined models from Aim 2 in a pre/post study by assessing (a) process of care measures, (b) provider satisfaction, (c) caregiver/patient-centered outcomes, and (d) clinical outcomes and healthcare utilization.

Study point of contact

Seethal Jacob, MD
[email protected]


< 21 Years


Not Applicable

Study type






participation requirements

Patients must be between 0 to 21 years old with Sickle Cell Disease and receive care at the Riley Hospital for Children Comprehensive Sickle Cell Disease clinic.
The family must be willing to receive their care using the telemedicine model available to them based on the location of their primary residence.
TeleSCD model participants must live within 1 hour of the pre-identified telemedicine sites, while VirtualSCD model participants must live within the city limits of the pre-identified area.

participation restrictions

If a patient receives chronic transfusion therapy, they will not be eligible to participate, as our telemedicine models will not support this.

Last updated 2023-03-13